全球参数优化和抗毒药物药理动力学和药理动力学敏感性分析
Natalie M Morris1, Johanna A Blee1, Sabine Hauert1
1Department of Engineering Mathematics, Ada Lovelace Building, University of Bristol, University Walk, Bristol, BS8 1TW, UK.
概括
计算机建模揭示了有效的蛇抗毒设计的关键特性. 快速结合动力学 (kon) 对于疗效至关重要,特别是在延迟治疗时,指导未来的抗毒药开发.
科学领域:
- 药理学 药理学是指药理学的学科.
- 计算生物学 计算生物学
- 毒理学 毒理学 毒理学
背景情况:
- 蛇咬抗毒剂可以设计具有各种各样的药理动力学特性.
- 抗毒架的选择影响中和覆盖范围,这是由于毒素的药物动力学变化.
- 计算方法允许对毒剂处理系统进行评估,并模拟具有相同中和能力的抗毒剂.
研究的目的:
- 通过模拟来定义有效抗毒物的特性.
- 为优化抗毒设计建立一个计算框架.
主要方法:
- 模拟的全身毒化和治疗,使用两部分的药理动力学模型.
- 纳贾苏马特拉纳和Cryptelytrops purpureomaculatus中毒的模拟治疗,使用20万个理论抗毒剂在10个时间延迟.
- 多种理论抗毒参数包括分子量,剂量,结合率 (kon),解离率 (koff) 和价值.
- 使用曲线下的面积确定了最佳和次优治疗方法,并进行了全球灵敏度分析.
主要成果:
- 多种分子抗毒基架可以有效.
- 分子重量和价值显示微不足道的直接影响;低分子重量支架提供灵活性,特别是延迟处理.
- 关联率 (kon) 主要介导疗效,需要率> 10^5 M-1s-1的最佳治疗.
- 分离率 (koff) 显著影响不太有效的支架.
- 对C. purpureomaculatus中毒的参数界限比N. sumatrana的限制更为有限.
结论:
- 这项研究为优化抗毒设计提供了一个计算框架.
- 快速结合动力学 (kon) 对抗毒药的有效性至关重要.
- 低分子量抗毒剂可能在灵活性方面提供优势,特别是当治疗延迟时.
相关概念视频
01:12Analysis of Population Pharmacokinetic Data
301
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
301
00:59Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
97
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
97
01:20Pharmacokinetic Models: Overview
813
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
813
00:54Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters
136
The noncompartmental approach is a widely used method in pharmacokinetics to assess drugs' behaviors in the body. It considers several factors, including clearance, bioavailability, and total volume of distribution.
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
136
01:26Pharmacokinetic Models: Comparison and Selection Criterion
109
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
109
01:22Nonlinear Pharmacokinetics: Bioavailability and Protein-Drug Binding
212
When a drug follows nonlinear pharmacokinetics, its bioavailability, the amount of the drug that reaches the systemic circulation, can change with different doses. This is due to the presence of a saturable pathway. The pathway becomes saturated as the drug concentration increases, decreasing the absorption rate. Consequently, the drug's bioavailability may be lower than expected at higher doses.
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
212